Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

GlobalFoundries Stock (GFS) Today: Nasdaq-100 Exit, EU Funding Boost, GaN Partnerships, and What Analysts Forecast Next

GlobalFoundries Stock (GFS) Today: Nasdaq-100 Exit, EU Funding Boost, GaN Partnerships, and What Analysts Forecast Next

December 20, 2025 — GlobalFoundries Inc. is heading into year-end with an unusually dense cluster of catalysts for a “specialty foundry” name: an impending removal from the Nasdaq-100, fresh Europe-leaning policy support, a string of power-semiconductor partnerships, and a strategic push deeper into silicon photonics—one of the most hyped bottlenecks in AI-era infrastructure.
20 December 2025
··
Micron Technology Stock (MU) News Today, Dec. 20, 2025: Earnings Blowout, AI Memory Boom, and Updated Wall Street Price Targets

Micron Technology Stock (MU) News Today, Dec. 20, 2025: Earnings Blowout, AI Memory Boom, and Updated Wall Street Price Targets

Micron Technology, Inc. is ending the week at the center of the semiconductor conversation—and not just because “AI” is the word of the decade. As of Dec. 20, 2025, Micron stock is trading around $265.92, after a volatile stretch that included a post-earnings surge and fresh debate about how long the memory upcycle can stay “too tight to breathe.”
20 December 2025
···
Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals, Inc. heads into the weekend of December 20, 2025 with investors still digesting a fast-moving sequence of catalysts: fresh clinical data for its lead program REC-4881, a notable JPMorgan upgrade, and a burst of unusually heavy trading volume that has kept the stock in the spotlight.
20 December 2025
···
Pfizer Stock (PFE) News Today: 2026 Guidance, TrumpRx Drug-Pricing Deals, Dividend, and Analyst Forecasts (Dec. 20, 2025)

Pfizer Stock (PFE) News Today: 2026 Guidance, TrumpRx Drug-Pricing Deals, Dividend, and Analyst Forecasts (Dec. 20, 2025)

Pfizer Inc. stock is ending the week in a familiar place: the mid-$20s. But the story behind that “quiet” price is anything but quiet. Investors are weighing Pfizer’s newly issued 2026 outlook, an evolving U.S. drug-pricing landscape tied to the TrumpRx / most-favored-nation framework, and a pipeline-and-deal strategy meant to carry the company through a multi-year patent cliff and the long fade of COVID-era revenue. Reuters+1
20 December 2025
···
Plug Power Stock (NASDAQ: PLUG) Today: Latest News, Analyst Forecasts, and What Wall Street Is Watching on Dec. 20, 2025

Plug Power Stock (NASDAQ: PLUG) Today: Latest News, Analyst Forecasts, and What Wall Street Is Watching on Dec. 20, 2025

Plug Power Inc. heads into the weekend in a familiar state for longtime shareholders: high volume, high volatility, and a constant tug‑of‑war between “hydrogen is inevitable” and “cash flow is not optional.” With U.S. markets closed Saturday, the most recent reference point is Friday’s close, when PLUG finished at $2.20, down 2.65% on the day—despite a broadly positive session for major indexes. MarketWatch
20 December 2025
··
Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media (DJT) Stock Jumps After $6 Billion Fusion Merger Plan: Latest News, Forecasts, and What Investors Are Watching (Dec. 20, 2025)

Trump Media & Technology Group Corp. is ending the week the way it often lives: loudly, unpredictably, and with traders glued to their screens. After announcing a surprise plan to merge with nuclear fusion developer TAE Technologies in a deal valued at more than $6 billion, DJT shares ripped higher on massive volume—turning a social-media stock into a new way to bet on the race to power the AI era. GlobeNewswire+2StockAnalysis+2
20 December 2025
···
Denison Mines Stock (DNN, DML) News and Forecast for Dec. 20, 2025: Skyharbour JV Deal, Phoenix ISR Permitting, and Analyst Price Targets

Denison Mines Stock (DNN, DML) News and Forecast for Dec. 20, 2025: Skyharbour JV Deal, Phoenix ISR Permitting, and Analyst Price Targets

Dec. 20, 2025 — Denison Mines Corp. heads into the weekend with fresh catalysts on the tape: a newly closed exploration joint-venture restructuring next door to its flagship Wheeler River project, multiple community-benefit agreements aimed at strengthening “social license” in northern Saskatchewan, and a mix of analyst and technical takes that have kept the uranium developer firmly on investors’ radar. Denison Mines Corp.+2Denison Mines Corp.+2
20 December 2025
··
Intel Stock (INTC) News and Forecast for Dec. 20, 2025: Nvidia Deal Cleared, Foundry Milestones, and What Analysts See Next

Intel Stock (INTC) News and Forecast for Dec. 20, 2025: Nvidia Deal Cleared, Foundry Milestones, and What Analysts See Next

Dec. 20, 2025 — Intel Corporation heads into the weekend with its stock back in the center of the semiconductor conversation: not just because shares have staged a dramatic 2025 rebound, but because a fast-moving mix of regulatory headlines, foundry progress, and analyst debate is reshaping the bull and bear cases in real time.
20 December 2025
··
Cisco Stock (CSCO) News and Forecasts on Dec. 20, 2025: AI Networking Tailwinds, Security Zero‑Day Risk, and Fresh Wall Street Targets

Cisco Stock (CSCO) News and Forecasts on Dec. 20, 2025: AI Networking Tailwinds, Security Zero‑Day Risk, and Fresh Wall Street Targets

Cisco Systems, Inc. is having a very 2025 moment: a legacy networking giant that spent years looking “mature” is suddenly back in the market’s spotlight—helped by the AI infrastructure buildout, a return to post–dot-com-era highs, and an investor-friendly capital return story. At the same time, Cisco is dealing with the kind of headline risk that follows security vendors everywhere: a critical, actively exploited vulnerability affecting certain Cisco email security products. Financial Times+2Canadian Centre for Cyber Security+2
20 December 2025
··
Comcast Stock (CMCSA) on Dec. 20, 2025: Versant Spinoff Details, Activist Buzz, and Analyst Forecasts Driving the Next Move

Comcast Stock (CMCSA) on Dec. 20, 2025: Versant Spinoff Details, Activist Buzz, and Analyst Forecasts Driving the Next Move

Comcast Corporation stock finished the latest session in retreat, closing at $29.57 on Friday, December 19, down 2.31%, even as broader markets rose. Trading activity was unusually heavy—about 85 million shares changed hands versus a recent daily average near 35 million—suggesting investors are actively repositioning around a dense cluster of catalysts: the approaching Versant spinoff, renewed activist-investor speculation, and a steady stream of fresh analyst notes into year-end. MarketWatch
20 December 2025
Tesla Stock News Today (Dec. 20, 2025): TSLA Weighs Musk Pay Ruling, California Autopilot Scrutiny, and Diverging Delivery Forecasts

Tesla Stock News Today (Dec. 20, 2025): TSLA Weighs Musk Pay Ruling, California Autopilot Scrutiny, and Diverging Delivery Forecasts

Tesla, Inc. heads into the Dec. 20, 2025 weekend parked near rarefied air—yet surrounded by the kind of headline turbulence that only Tesla can manufacture at scale. Shares last traded around $481 after Friday’s session, with investors digesting a major legal win for CEO Elon Musk, fresh regulatory pressure on Tesla’s self-driving branding, and a widening gap between delivery expectations and “robotaxi/AI” valuation narratives. Reuters+1
20 December 2025
··
Rocket Lab (RKLB) Stock in Focus on Dec. 20, 2025: $816M SDA Satellite Win, Faster Launch Cadence, and Neutron’s 2026 Countdown

Rocket Lab (RKLB) Stock in Focus on Dec. 20, 2025: $816M SDA Satellite Win, Faster Launch Cadence, and Neutron’s 2026 Countdown

December 20, 2025 — Rocket Lab Corporation enters the weekend with investors re-pricing what the company actually is: not “just a small-rocket shop,” but an increasingly serious national security space contractor with an expanding space-systems footprint and a medium-lift rocket program nearing its critical first-flight phase. Rocket Lab+1
20 December 2025
·
Rivian Stock (NASDAQ: RIVN) Surges on AI and Autonomy Push: Latest News, Analyst Forecasts, and What Comes Next (Dec. 20, 2025)

Rivian Stock (NASDAQ: RIVN) Surges on AI and Autonomy Push: Latest News, Analyst Forecasts, and What Comes Next (Dec. 20, 2025)

Rivian Automotive, Inc. is closing out 2025 with the kind of momentum that can make even long-suffering EV investors sit up straighter. The stock was recently trading around $22.45 after a sharp, high-volume move in the latest session—one of Rivian’s most attention-grabbing bursts since 2023.
20 December 2025
···
Warner Bros. Discovery stock today: Netflix deal vs Paramount $30 bid, analyst forecasts, and what’s next — Dec. 20, 2025

Warner Bros. Discovery stock today: Netflix deal vs Paramount $30 bid, analyst forecasts, and what’s next — Dec. 20, 2025

Warner Bros. Discovery, Inc. stock has turned into a real-time market referendum on one question: which takeover path actually closes. As of the latest available quote, WBD shares were around $27.77, leaving the stock effectively pinned near Netflix’s agreed $27.75-per-share value while still sitting below Paramount Skydance’s $30 all-cash tender offer.
20 December 2025
····
Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

Amicus Therapeutics, Inc. is having the kind of week biotech traders both crave and fear: a sudden, definitive catalyst that snaps the stock to a new reality overnight. On Friday, December 19, shares jumped about 30% and hovered around $14.18, after BioMarin Pharmaceutical announced a $14.50-per-share all-cash acquisition valuing Amicus at roughly $4.8 billion. Reuters+1
20 December 2025
··
1 … 435 436 437 438 439 … 609
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 STRONG BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 BUY

Chevron

NYSE: CVX 86 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.